Examining the medtech M&A boom: global forces operating on the sector
Livingstone has curated a panel of CEOs, OEMS and private equity investors to discuss key drivers of the medtech M&A boom.
We will explore why medtech assets are trading at premium prices, discuss how consolidation in the global medtech industry is impacting companies throughout the supply chain and ask what the future holds for medtech industry participants.
Karl Freimuth, partner and co-head of the US industrials practice at Livingstone will moderate the discussion at mHUB Chicago on Thursday, November 15, 2018.
